Glucagon-like peptide-1 (GLP-1), an incretin secreted by intestinal L-cells, can effectively lower blood glucose levels in patients with diabetes. A fusion gene, consisting of 10 tandem repeated GLP-1 analog genes, was expressed at a high level in the yeast Pichia pastoris. SDS polyacrylamide gel electrophoresis (SDS-PAGE), and Western Blotting results showed that fusion protein migrated as a single protein band with a molecular weight of 36 kDa. A biological activity test showed that the GLP-1 analog could significantly lower the level of serum glucose when GLP-1 purified analog was injected into diabetic rats. A potential strategy for large-scale production of fusion protein containing the 10 GLP-1 analogs as discovered, and a single GLP-1 analog was obtained from fusion protein digested with trypsin. This should be inspired foreign expression of medicinal short peptides and be valuable in further research on GLP-1 analog drugs in the treatment of diabetes mellitus.
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The gut hormone glucagon like peptide-1 (GLP-1) is produced in intestinal endocrine L-cells. It is a Cterminally amidated 30 amino-acid peptide, which is processed from proglucagon and secreted into the blood stream after meals. GLP-1 can stimulate insulin secretion, inhibit glucagon secretion, delay gastric emptying and exert, perhaps, a peripheral stimulatory action on glucose uptake. Intravenous or subcutaneous GLP-1 administration has shown that GLP-1 exerts antidiabetogenic action by reducing basal and postprandial glucose concentrations in subjects with type 1 or type 2 diabetes, [1] [2] [3] [4] [5] [6] and it has been shown to have effects oncells. 7) Not only does it stimulate -cell proliferation 8, 9) but it also enhances the differentiation of new -cells from progenitor cells in the pancreatic duct epithelium. 10) Most recently, GLP-1 has been shown to inhibit apoptosis of -cells, including human -cells.
11) These actions render GLP-1 highly attractive as a therapeutic agent, and GLP-1 based therapy has unusually attractive potential in type 1 and 2 diabetes treatment.
The methylotrophic yeast Pichia pastoris (P. pastoris) was developed as an expression system for the efficient production of foreign proteins.
12) It has the advantages of high production yields, genetically stable expression strains, the potential to secrete recombinant proteins freely into the medium, and inexpensive culture conditions. The engineering strain of P. pastoris is very suitable for large-scale production in industry.
Therefore, it is promising if GLP-1 analog is produced by the P. pastoris expression system. Presently, there are no reports about the expression of GLP-1 analog in the yeast P. pastoris. GLP-1 analog is a short peptide (30 AA), too small to be conveniently purified from the culture supernatant by general methods, so it is necessary to put forward a new expression strategy.
This paper demonstrates that a fusion gene, containing 10 tandem repeated GLP-1 analog genes, is expressed at a high level in P. pastoris, and that the fusion protein, named GLP-M protein, is digested by trypsin to produce a single GLP-1 analog. These studies not only increase the yield of GLP-1 analog, but also solve problems in protein purification, a foundation for largescale production of single GLP-1 analog in industry.
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Materials and Methods
Strains and plasmids. The methylotrophic yeast P. pastoris strain GS115 (deficient in histidinol dehydrogenase activity, His À ) and plasmid pPIC9K were purchased from Invitrogen (Carlsbad, CA, USA). Escherichia coli (E. coli) strain DH5 was used for transformation and propagation of the recombinant plasmids. The vector of pMDGLP-1 was conserved in our laboratory, and will be described elsewhere.
Enzymes and chemicals. Restriction endonucleases, T4 DNA ligase, pMD18T-Vector, pfu Taq DNA polymerase and agar gel DNA extraction kit were obtained from Takara (Tokyo, Japan). The low molecular weight protein marker standard for electrophoresis was purchased from Bio-Dev (Beijing, China). Anti-his antibody and goat anti-mouse IgG-HRP were purchased from Tiangen Biotech. (Beijing, China). The synthesis of primers and the detection of DNA sequences were performed by Invitrogen (Carlsbad, CA). Other chemicals were purchased from local companies in Tianjin, China.
Construction of clone vector pMDGLP-A. A DNA fragment encoding a single GLP-1 analog was amplified by PCR using pMDGLP-1 as template. The following oligonucleotide primers were used: sense, 5
0 -GATATC-AGACATTCTGAGGGAAC-3 0 , and antisense, 5 0 -CCCGGGACGGCCATCTACG-3 0 (the underlined nucleotides in the sense strand indicate the location of an EcoRV site, while those in the antisense strand indicate the location of a SmaI site). PCR product was subcloned into clone vector pMD18-T. Then selection was performed to find a clone; the two SmaI sites lay on the two sides of a single GLP-1 analog gene. Clone vector pMDGLP-A was successfully constructed. Construction of clone vector pMDGLP-B2. A PCR fragment of 2 Â GLP was amplified by PCR using pMDGLP-B as template. The sequences of the primers for this PCR were as follows: sense, 5 0 -TCCCGGG-TAGACATTCTGAGGGAAC-3 0 , and antisense, 5 0 -TGCGGCCGCTTAGTGGTGGTGGTGGTGGTGGA-TATCACGGCCATCTACG-3 0 (the underlined nucleotides in the sense strand show the location of a SmaI site, while those in the antisense strand show the location of a NotI site). There are 18 bases encoding a tag of six histidine residues (6 Â His) and an EcoRV site in the antisense strand. PCR-product was subcloned into pMD18-T vector with the purpose of getting the clone vector pMDGLP-B2, which contained two SmaI sites at the either end of 2 Â GLP.
Construction of clone vector pMDGLP-M. A DNA fragment of 8 Â GLP was acquired from clone vector pMDGLP-D digested with EcoRV and SmaI, then exactly inserted into the EcoRV site of pMDGLP-B2 treated with CIAP after being digested with EcoRV. The clone vector with 10 Â GLP was named pMDGLP-M.
Construction of expression vector pPIC9KGLP-M. P. pastoris expression vector pPIC9K was treated with pfu DNA polymerase after being digested with EcoRI and then digested with NotI. Moreover, a DNA fragment of 10 Â GLP was obtained after pMDGLP-M was digested with NotI and SmaI, and was ligated with a DNA fragment of pPIC9K to generate expression vector pPIC9KGLP-M (Fig. 1) . The clone vectors of pMD-GLP-A, pMDGLP-B, and pMDGLP-B2 were confirmed by DNA sequencing. Other vectors were confirmed by restriction digestion.
Transformation of P. pastoris and screening for multicopy transformants by G418 selection. Electrocompetent cells of P. pastoris strain GS115 were transformed with the SacI-linearized expression plasmid pPIC9KGLP-M by electroporation at 1.5 kV, 25 mF, and 200 .
13) The cells were incubated on MD (minimal dextrose medium) plates (1.34% yeast nitrogen base, 4 Â 10 À5 % biotin, 2% dextrose, and 2% agar, w/v) for 3-5 d at 30 C, and were used to select transformants with the His þ utilization phenotype. Single colonies from the MD plate were carefully removed under sterile conditions and patched to YPD-G418 medium (1% yeast extract, 2% peptone, 2% dextrose, 2% agar, and 4 mg/ml G418), and incubated for 3-5 d at 30 C in order to select multicopy transformants. Some clones grown on 4 mg/ml G418 YPD plates, which indicated that multicopy expression cassettes were inserted into the GS115 genomic DNA, and were selected to get an engineering strain, which would express fusion protein GLP-M at a high level.
Southern dot blotting analysis. A 100 ng DNA fragment of 10 Â GLP was obtained from expression vector pPIC9KGLP-M digested with BamHI and NotI, and treated to become a DNA probe according to the kit instructions. Genomic DNA of the P. pastoris transformants after 48 h methanol induction was isolated by the method described previously. 14) Then southern dot blotting was performed according to the instructions of the Electrochemiluminescence (ECL) Direct Nucleic Acid Labeling and Detection Systems Kit (Amersham, Uppsala, Sweden). pPIC9K plasmid and strain GS115-p9k, from GS115 transformed with the vector pPIC9K, genomic DNA were used as negative controls.
Optimization of GLP-M protein expression conditions. Some factors were tested, such as pH value, inductive duration time, the methanol concentration, dodecane, oleic acid, and Tween-80. Small-scale cultures inoculated in 20 ml of buffered glycerol-complex medium (BMGY) were vigorously shaken at 28-30 C. The cells were cultured for 2 d and then collected by centrifugation. The cell pellet was resuspended in 20 ml of buffered methanol-complex medium (BMMY) in a 250-ml shaking flask and induced to express GLP-M protein under various conditions. The optimum condition for GLP-M protein expression was achieved by single factor and orthogonal tests. The corresponding levels of single factors, such as the initial pH value (4.0, 5.0, 6.0, 7.0, or 8.0), the inductive duration time (1, 2, 3, 4, 5, 6, or 7 d) and the methanol concentration (0.5, 1.0, 1.5, or 2.0%, v/v), were determined. The corresponding levels of the orthogonal test, such as the dodecane concentration (3%, 4%, or 5%, v/v), the oleic acid concentration (0.005%, 0.01%, or 0.015%, v/v), and the Tween-80 concentration (0.3%, 0.4%, or 0.5%, v/v), were all performed.
SDS-PAGE and Western blotting analysis. The culture was centrifuged at 10000 g for 5 min at room temperature after it was induced for 4 d. The culture supernatant was concentrated with methanol and chloroform (3:1, v/v), and SDS-PAGE (SDS polyacrylamide gel electrophoresis) was performed to investigate protein production and purity using slab gels containing 10% (w/v) polyacrylamide on a mini-protean II slab cell apparatus (Bio-Rad, Hercules, CA). Protein samples were visualized by Coomassie brilliant blue R-250 staining. The samples from the SDS-PAGE gels were transferred to a membrane of polyvinylidene difluoride (PVDF, Millipore, Billerica, MA), as previously described. 15) Western blotting analysis 16) was performed using mouse monoclonal antibody against His-tag as primary antibody and peroxidase-conjugated goat anti-mouse IgG as secondary antibody.
Determination of secretive proteins. To determine the content of secretive protein, we constructed a standard graph with bovine serum albumin (BSA) as the standard by the Bradford method. The calibration graph shows a linear relation if the concentration of BSA is maintained in a range of 2.5-15 mg.
17) The expression level of objective protein GLP-M was assessed by densitometric scanning using Glyko Bandscan version 5.0 software analysis to get the percentage of GLP-M protein to total secretive proteins, which was evaluated by the Bradford method. In this assay, the yield of protein GLP-M is properly determined by multiplying the percentage by the total protein yield.
Protein purification. First, fermentation supernatant was precipitated with ammonium sulfate. After dialysis, secretive protein was then desalted by gel-filtration chromatography using a Sephadex G-25 column (1:0 cm Â 5:0 cm), and elution with 0.02 M sodium phosphate buffer. The protein sample was concentrated by lyophillization, and resolved in 0.02 M Tris-Cl buffer, pH 6.5. The DEAE-cellulose column (1:0 cm Â 40 cm) was equilibrated with 0.02 M Tris-Cl buffer. Next, the protein solution was loaded onto the column (1 ml/min), and bound GLP-M protein was desorbed by washing with equilibration buffer containing 0.3 M NaCl, then collected and applied to an affinity Ni-Particles column. Purification of His-tagged GLP-M was performed with a MagneHisÔ protein purification kit (Promega, Madison, WI), and GLP-M fusion protein was desorbed with elution buffer, and after lyophilization, stored at À20 C for further analysis. Trypsin (Sigma, St. Louis, MO) digestion of GLP-M was carried out in 0.9% NaCl, pH 7.6, at a trypsin concentration of 0.1% at 37 C for 2 h. 18) A single GLP-1 analog was separated from trypsin reaction solution by gel-filtration chromatography column and stored at À20 C for further analysis.
Biological activity test. Sixty male Wistar rats of body weight 200 AE 10 g were purchased from the Academy of Military Medical Sciences (Beijing, China) and rendered a diabetic animal model of hyperglycemia by a single intravenous injection of streptozotocin (Sigma, St. Louis, MO; STZ in citrate buffer, pH 4.5) into the tail vein at a dose of 65 mg/kg of body weight. 19) All animals were housed in individual cages in a room controlled at 23 AE 2 C, humidity (45 AE 5%), and light (08:00-20:00), and maintained on a standard diet and water. The plasma glucose levels of the rats were measured in tail vein blood samples with an Accu-Chek active glucose test kit (Roche Diagnostics, Mannheim, Germany).
Fifty male rats with blood sugar values of 15:9 AE 1:8 mmol/l were selected for a GLP-1 analog test, and the animals were randomly divided into five groups (10 rats in each group): 0.9% NaCl control group, 50 mg/kg/d treated group, 100 mg/kg/d treated group, 200 mg/kg/d treated group, human insulin treated group (20 U/kg/d). Drug effect tests began on the eighth day. GLP-1 analog was solved with 0.9% NaCl and used in the assay of the biological activity test. All test rats were treated for 7 d, and the serum glucose level was determined by the above method.
Space structure and characteristics analysis. Single GLP-1 analog space structure was predicted by software Swiss-Pdbviewer 3.7 for recognizing a specific PDB file which was obtained after its amino acid sequence was submitted to the web site (http://swissmodel.expasy. org/). Estimation of pI and the molecular weight of fusion protein GLP-M were performed to the web site of online (http://au.expasy.org/tools/pi tool.html).
Statistical analysis. All experiments were performed at least three times to ensure reproducibility. Data analysis was carried out using the software SAS version 9.0.
Results

Construction of expression vector pPIC9KGLP-M
Clone vectors pMDGLP-A, pMDGLP-B, and pMD-GLP-B2 were confirmed by DNA sequencing. pMD-GLP-C, pMDGLP-D, pMDGLP-M, and pPIC9KGLP-M were constructed according to the above methods ( Fig. 1) and confirmed by restriction enzyme digestion.
Southern dot blotting
After the GS115 strain was transformed with linearized plasmid pPIC9KGLP-M, some recombinants of high copies numbers was selected on the G418-YPD plate, and confirmed by southern dot blotting. As shown in Fig. 2 , five P. pastoris engineering strain recombinants, named NK10 to 14, displayed a positive hybridization signal, indicating that the fusion gene was integrated into GS115 genomic DNA. The hybridization signal of NK10 was weaker than other strains, and possibly the number of expression cassettes integrated into GS115 genomic DNA were fewer than in other recombinants.
Optimization of GLP-M protein expression conditions in shake-flask culture of recombinant GS115 strain Effect of pH value in the initial BMMY medium pH has been shown significantly to affect the secretion of recombinant proteins due to protease activity in fermentation broth in P. pastoris, 12) so pH value is very important for the expression levels of recombinant proteins. We designed five levels of pH value (4.0, 5.0, 6.0, 7.0, or 8.0). Other inductive conditions conducted were 28 C, 230 r/min, 1% methanol final concentration added every 24 h continuously induced for 3 d. Twentyfour recombinants from the 4 mg/ml G418 YPD plate were chosen to be induced. It was seen that five recombinants (NK10 to 14) showed a special protein band of 36 kDa from the pH 7.0 medium as compared with the negative control, while the others did not display the special protein band from pH 4.0 to 8.0 medium (data not shown). The discoverable molecular weight of the special protein was uniform with the theoretical value of GLP-M protein. P. pasrotis engineering strain NK12 was selected and induced under different pH value conditions (Fig. 3) . The optimum pH 7.0 in the initial BMMY medium was confirmed for further inductive expression.
Effect of inductive duration time
The inductive duration time is crucially important to the production of secretive proteins when a foreign gene is expressed in the yeast P. pastoris. So it is required that the appropriate inductive duration time be ascertained in the expression of GLP-M protein. The culture of strain NK12 was tested from 1 to 7 d, and the other inductive conditions were pH 7.0, 28 C, 230 r/min, and 1% methanol of final concentration added every 24 h. The 100 ml culture supernatant was drawn out in a 1. Effect of the methanol concentration Alcohol oxidase (AOX1) is strongly induced by methanol. Under the control of the AOX1 promoter, the foreign gene is expressed at a high level when methanol is used as the sole carbon source, and which expression is repressed by most other carbon sources. 12) Control of the methanol concentration is mainly to avoid accumulation of methanol at high levels, as an excess of methanol leads to accumulation of formaldehyde, the first product of methanol metabolism, to toxic levels. 20) So the appropriate concentration of methanol is important to the expression of GLP-M protein when recombinant GS115 strain is induced with methanol. Strain NK12 was selected to test GLP-M protein expression under different methanol concentrations, added every 24 h. We detected four levels of methanol concentration (0.5%, 1.0%, 1.5%, or 2.0%) to induce expression. The other fermentation conditions were pH 7.0, 28 C, 230 r/min, induced for 4 d. Under a methanol concentration of 1.5% added every 24 h, the yield of GLP-M protein of 30.8 mg/l was higher than the others (p < 0:01). A methanol concentration of 1.5% was the optimum for inductive expression of GLP-M protein.
Effect of dodecane, oleic acid, and Tween-80 To achieve a high yield of GLP-M protein in the fermentation process, we were particularly attentive to certain additives at the initiation of induction, such as dodecane, oleic acid, and Tween-80. An orthogonal test was designed to study further the influence of three factors (dodecane, D; oleic acid, O; and Tween-80, T) on the yield of GLP-M proteins in recombinant GS115 strain NK12. The analytical results of the orthogonal test showed that factors D and T had significant influence on the yield of GLP-M protein (p < 0:01), and the relationships between O and T, inclusive of that of the three factors, were significantly correlated (p < 0:01). The highest mean yield of GLP-M proteins was 219.2 mg/l at the optimal treatment (D2, O2, T3). Consequently, the optimal condition for shake-flask fermentation of GLP-M protein expression was as follows: pH 7.0, 28 C, 230 r/min, induction for 4 d, 1.5% methanol added every 24 h, addition of 4% dodecane, 0.01% oleic acid, and 0.5% Tween-80 at the initial period of induction.
Determination of GLP-M protein and Western blotting analysis
The 20 ml crude supernatant under the optimum condition (D2, O2, T3) was directly subjected to SDS-PAGE analysis (Fig. 4A) . The results of Western blotting analysis revealed that GLP-M protein was exactly expressed in P. pastoris (Fig. 4B) .
Protein purification and biological activity test According to the method described above, GLP-M protein was purified from culture supernatants after 4 d of induction under the optimal fermentation condition. The purified GLP-M fusion protein was then digested with trypsin to produce single GLP-1 analog with the Nterminus and C-terminus extra amino acids removed (Fig. 5) . The GLP-M protein and single GLP-1 analog were analyzed by Tricine-SDS-PAGE (16.5%) (Fig. 6) .
Moreover, a preliminary bioactivity test with hyperglycemic rats showed that the serum glucose was significantly lowered from 16:5 AE 2:0 mmol/l to 9:9 AE 1:2 mmol/l by a dose of GLP-1 analog 200 mg/kg/d for 7 d (p < 0:001) (Fig. 7) .
Space structure and characteristics analysis Some characteristics of GLP-M protein can be predicted by submitting its amino acid sequence to Expasy server. The pI value and molecular weight of GLP-M was about 4.37 and 36 kDa respectively. The single GLP-1 analog was obtained after GLP-M was digested with trypsin. The space structure of single GLP-1 analog is shown in Fig. 8 . It has been reported that the histidine of the GLP-1 (7-36) N-terminus and the last three C-terminus residues are very important in improving insulin secretion and maintaining biological activity. 21) The result of space structure discloses a secondary structure of alpha helix from Ser8 to Trp25, similarly the native GLP-1.
22)
Discussion
In the present study, we developed, for the first time, a successful protocol for expression of GLP-M protein containing 10 GLP-1 analogs in P. pastoris. GLP-M protein is expressed by optimizing the fermentation condition at a high level. It was concluded that 1 mole GLP-M protein, after being digested with trypsin, can produce 10 moles of single GLP-1 short peptides, since the cleavage sites-Arg of trypsin exit at the first amino acid before the N-terminus and the final amino acid of the C-terminus of the single GLP-1 analog (Fig. 5) . Thus the yield of the single GLP-1 analog is greatly increased by the expression strategy of multi-copy GLP-1 analogs.
It has been reported that natural GLP-1 (7-36) is rapidly degraded by dipeptidyl peptidase IV (DPP-IV), a highly specialised exopeptidase that removes a dipeptide, His-Ala, from the N-terminus, forming GLP-1 (9-36) amide. 23) The rapid inactivation of natural GLP-1 in the circulation has a biological half-life of less than 5 min. [24] [25] [26] To overcome this problem, in this study, we substituted a serine for alanine at the eighth amino acid position of a GLP-1 analog ([Ser 8 , Gln 26 , Asp 34 ]-GLP-1) to determine whether this mutant exhibits insulinotropic activity without succumbing to rapid degradation by DPP-IV (Fig. 5) . Moreover, substituting glutamine 26 and aspartic acid 34 for two lysine residues (lys 26 , lys 34 ) is convenient with GLP-M protein degradation by trypsin. The results were that the recombinant GLP-1 analog can significantly decrease the serum glucose level of diabetic rats.
Although Hohmann reported that five invertase genes located in a multicopy vector are cloned and expressed in the yeast Saccharomyces cerevisiae, 27) we suggest a new idea about the expression of the short gene, that the fusion gene including 10 short genes, is expressed in P. pastoris and a short peptide is obtained from the fusion protein digested by trypsin.
This potential strategy is significant for the production of the GLP-1 analog in industry. Large-scale production in a fermenter is ongoing in our laboratory. This study should be valuable for further research on GLP-1 analog short peptide drugs in the treatment of diabetes mellitus.
